WELL Health Technologies Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA94947L1022
CAD
3.99
-1.54 (-27.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
356.67
294.14
193.24
251.74
243.15
231.56
231.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
356.67
294.14
193.24
251.74
243.15
231.56
231.25
Raw Material Cost
223.33
196.21
173.04
156.96
153.07
145.90
146.96
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
63.98
45.53
42.19
38.59
41.02
42.31
41.95
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.70
11.41
9.08
8.90
9.56
9.33
8.65
Selling and Distribution Expenses
104.44
86.33
84.14
76.91
75.94
73.08
72.17
Other Expenses
-7.67
-5.69
-5.13
-4.75
-5.06
-5.16
-5.06
Total Expenditure (Excl Depreciation)
327.77
282.54
257.18
233.88
229.02
218.98
219.13
Operating Profit (PBDIT) excl Other Income
28.900000000000002
11.6
-63.9
17.9
14.1
12.6
12.1
Other Income
-0.12
-1.61
-20.44
-0.04
-1.72
9.15
-1.23
Operating Profit (PBDIT)
54.18
29.54
-63.41
35.30
29.72
38.30
27.65
Interest
12.70
11.41
9.08
8.90
9.56
9.33
8.65
Exceptional Items
6.95
-39.32
44.30
-81.75
111.99
8.08
32.41
Gross Profit (PBDT)
133.34
97.93
20.20
94.78
90.07
85.66
84.28
Depreciation
25.39
19.55
20.96
17.48
17.31
16.56
16.76
Profit Before Tax
23.04
-40.73
-49.16
-72.83
114.84
20.49
34.65
Tax
5.92
-1.23
-19.05
1.09
-1.96
-0.18
0.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
12.15
-46.57
-13.00
-81.19
111.72
15.09
27.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
12.15
-46.57
-13.00
-81.19
111.72
15.09
27.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.85
4.69
-18.73
5.44
5.26
4.51
5.95
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.00
-41.89
-31.73
-75.75
116.98
19.60
33.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
826.20
834.43
867.61
847.12
935.02
810.84
767.67
Earnings per share (EPS)
0.05
-0.19
-0.05
-0.33
0.43
0.06
0.12
Diluted Earnings per share
0.05
-0.19
-0.05
-0.33
0.43
0.06
0.12
Operating Profit Margin (Excl OI)
8.1%
3.94%
-33.09%
7.1%
5.81%
5.43%
5.24%
Gross Profit Margin
13.58%
-7.2%
-14.59%
-21.99%
54.35%
16.0%
22.23%
PAT Margin
3.41%
-15.83%
-6.73%
-32.25%
45.95%
6.52%
12.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 46.73% vs 42.25% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -85.47% vs 5,950.00% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 72.93% vs 26.10% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 32.29% vs 23.08% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of WELL Health Technologies Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
Net Sales
356.67
435.20
-78.53
-18.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
356.67
435.20
-78.53
-18.04%
Raw Material Cost
223.33
263.40
-40.07
-15.21%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
63.98
0.00
63.98
Power Cost
0
0
0.00
Manufacturing Expenses
12.70
21.70
-9.00
-41.47%
Selling and Distribution Expenses
104.44
139.60
-35.16
-25.19%
Other Expenses
-7.67
-2.17
-5.50
-253.46%
Total Expenditure (Excl Depreciation)
327.77
403.00
-75.23
-18.67%
Operating Profit (PBDIT) excl Other Income
28.90
32.20
-3.30
-10.25%
Other Income
-0.12
0.20
-0.32
-160.00%
Operating Profit (PBDIT)
54.18
78.60
-24.42
-31.07%
Interest
12.70
21.70
-9.00
-41.47%
Exceptional Items
6.95
-6.90
13.85
200.72%
Gross Profit (PBDT)
133.34
171.80
-38.46
-22.39%
Depreciation
25.39
46.20
-20.81
-45.04%
Profit Before Tax
23.04
3.80
19.24
506.32%
Tax
5.92
2.90
3.02
104.14%
Provisions and contingencies
0
0
0.00
Profit After Tax
12.15
0.90
11.25
1,250.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
12.15
0.90
11.25
1,250.00%
Share in Profit of Associates
0
0
0.00
Minority Interest
4.85
0.00
4.85
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.00
0.90
16.10
1,788.89%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
826.20
1,770.60
-944.40
-53.34%
Earnings per share (EPS)
0.05
0.00
0.05
Diluted Earnings per share
0.05
0.00
0.05
Operating Profit Margin (Excl OI)
8.10%
7.40%
0.00
0.70%
Gross Profit Margin
13.58%
11.49%
0.00
2.09%
PAT Margin
3.41%
0.21%
0.00
3.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 35.67 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 21.29% vs 52.23% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 46.73% vs 42.25% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 140.57% vs -32.18% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -85.47% vs 5,950.00% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.43 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 74.60% vs 172.33% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 72.93% vs 26.10% in Jun 2024

Quarterly - Interest
Interest 1.27 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 11.40% vs 25.27% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 32.29% vs 23.08% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.10%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024